Related references
Note: Only part of the references are listed.An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer
Domenico Tierno et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
How to conduct a systematic review and meta-analysis of prognostic model studies
Johanna A. A. Damen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2023)
Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis
Afshin Bahramy et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2023)
The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
Talita Araujo B. da S. Santana et al.
DIAGNOSTICS (2023)
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
Yanan Wu et al.
MOLECULAR DIAGNOSIS & THERAPY (2023)
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
Flavia Jacobs et al.
CANCERS (2023)
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave
Chiara Benvenuti et al.
CANCERS (2023)
Enigmatic role of exosomes in breast cancer progression and therapy
Paras Famta et al.
LIFE SCIENCES (2022)
Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review
Nhu Hanh To et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
Barbara Cardinali et al.
CANCERS (2022)
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
Satoko Takizawa et al.
CANCER BIOMARKERS (2022)
Multivariate meta-analysis of multiple outcomes: characteristics and predictors of borrowing of strength from Cochrane reviews
Miriam Hattle et al.
SYSTEMATIC REVIEWS (2022)
Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis
Thu H. N. Nguyen et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
Oana Baldasici et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective
Valentina Fogazzi et al.
CANCERS (2022)
Comprehensive characterization of RNA cargo of extracellular vesicles in breast cancer patients undergoing neoadjuvant chemotherapy
Lilite Sadovska et al.
FRONTIERS IN ONCOLOGY (2022)
Graphene Oxide-Based Highly Sensitive Assay of Circulating MicroRNAs for Early Prediction of the Response to Neoadjuvant Chemotherapy in Breast Cancer
Zhijia Li et al.
ANALYTICAL CHEMISTRY (2022)
Breast cancer cell-derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function
Junfeng Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Prognostic Implications of microRNA-155, -133a, -21 and -205 in Breast Cancer Patients’ Plasma
Aarthy Raghu et al.
MicroRNA (Shariqah, United Arab Emirates) (2021)
microRNAstrand selection: Unwinding the rules
Jeffrey C. Medley et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
circRNA-miRNA-mRNA in breast cancer
Meilan Zhang et al.
CLINICA CHIMICA ACTA (2021)
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Rosalba Torrisi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer
Yu Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
Zhuo Zhang et al.
THORACIC CANCER (2021)
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature
Chrystel Isca et al.
CANCERS (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Circulating miRNA analysis for cancer diagnostics and therapy
Lukas Valihrach et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy
Serena Di Cosimo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
Zhang Shan et al.
FRONTIERS IN ONCOLOGY (2020)
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
Andrew McGuire et al.
CANCERS (2020)
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
Barbara Pasculli et al.
FRONTIERS IN ONCOLOGY (2020)
Precision Health Analytics With Predictive Analytics and Implementation Research JACC State-of-the-Art Review
Thomas A. Pearson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
Zhen Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Multivariable logistic and linear regression models for identification of clinically useful biomarkers for osteoarthritis
Yulia Liem et al.
SCIENTIFIC REPORTS (2020)
Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
Anna Maria Grimaldi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes
Thomas P. A. Debray et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
A guide to systematic review and meta-analysis of prognostic factor studies
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Empirical comparison of univariate and multivariate meta-analyses in Cochrane Pregnancy and Childbirth reviews with multiple binary outcomes
Malcolm J. Price et al.
RESEARCH SYNTHESIS METHODS (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 128, 2019)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
Hui Wang et al.
BMC CANCER (2019)
Circulating MicroRNAs in Cancer: Potential and Challenge
Mengying Cui et al.
FRONTIERS IN GENETICS (2019)
Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab
Baoquan Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses
Dean Langan et al.
RESEARCH SYNTHESIS METHODS (2019)
PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2019)
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Robert F. Wolff et al.
ANNALS OF INTERNAL MEDICINE (2019)
Extracellular RNA profiles with human age
Douglas F. Dluzen et al.
AGING CELL (2018)
Triple negative breast cancer in Asia: An insider's view
Chao Wang et al.
CANCER TREATMENT REVIEWS (2018)
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Ines Stevic et al.
BMC MEDICINE (2018)
Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer
Wenjie Zhu et al.
CANCER MEDICINE (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
Solmaz Khalighfard et al.
SCIENTIFIC REPORTS (2018)
Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2
Xiao-Xiao Wang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Transforming the Area under the Normal Curve (AUC) into Cohen's d, Pearson's r(pb), Odds-Ratio, and Natural Log Odds-Ratio: Two Conversion Tables
Jesus F. Salgado
EUROPEAN JOURNAL OF PSYCHOLOGY APPLIED TO LEGAL CONTEXT (2018)
The roles of oncogenic miRNAs and their therapeutic importance in breast cancer
Samia O'Bryan et al.
EUROPEAN JOURNAL OF CANCER (2017)
Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer
Baoquan Liu et al.
HUMAN PATHOLOGY (2017)
A guide to systematic review and meta-analysis of prediction model performance
Thomas P. A. Debray et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
A guide to systematic review and meta-analysis of prediction model performance
Thomas P. A. Debray et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
Narayan Shivapurkar et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer
Baoquan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer
Doireann P. Joyce et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy
Zhen-Ru Liu et al.
LIFE SCIENCES (2016)
miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells
X-H He et al.
ONCOGENE (2016)
Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas
Jeremy T-H. Chang et al.
PLOS ONE (2016)
MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
Xinfeng Yu et al.
MOLECULAR CANCER (2015)
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
Leticia De Mattos-Arruda et al.
ONCOTARGET (2015)
Challenges in Using Circulating miRNAs as Cancer Biomarkers
Paola Tiberio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Joanna IntHout et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W. Kong et al.
ONCOGENE (2014)
Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
Qian Li et al.
PLOS ONE (2014)
An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes
Thomas A. Trikalinos et al.
STATISTICS IN MEDICINE (2014)
Smoking alters circulating plasma microvesicle pattern and microRNA signatures
Sigrun Badrnya et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
Karel G. M. Moons et al.
PLOS MEDICINE (2014)
Does regulation of skeletal muscle function involve circulating microRNAs?
Wataru Aoi et al.
FRONTIERS IN PHYSIOLOGY (2014)
Pre-analytical variables in miRNA analysis
Nils Becker et al.
CLINICAL BIOCHEMISTRY (2013)
miRNA profiling of cancer
Gianpiero Di Leva et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease
Hetty C. de Boer et al.
EUROPEAN HEART JOURNAL (2013)
Quantification of Circulating miRNAs in Plasma Effect of Preanalytical and Analytical Parameters on Their Isolation and Stability
Ioanna S. Sourvinou et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging
Dongliang Zhao et al.
PLOS ONE (2013)
Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
Wataru Aoi et al.
FRONTIERS IN PHYSIOLOGY (2013)
MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1
Chun-Mei Zhang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2013)
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Colin C. Pritchard et al.
CANCER PREVENTION RESEARCH (2012)
Lipid-based carriers of microRNAs and intercellular communication
Kasey C. Vickers et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
XenomiRs and miRNA homeostasis in health and disease Evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles
Kenneth W. Witwer
RNA BIOLOGY (2012)
Analytical challenges and technical limitations in assessing circulating MiRNAs
Anna Zampetaki et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Posttranscriptional Upregulation by MicroRNAs
Shobha Vasudevan
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
Radha Duttagupta et al.
PLOS ONE (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Strengths and Limitations of Laboratory Procedures for MicroRNA Detection
Jill Koshiol et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
Shuai Jiang et al.
CANCER RESEARCH (2010)
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T. Weigel et al.
ENDOCRINE-RELATED CANCER (2010)
MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer
William Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Receiver Operating Characteristic Curve in Diagnostic Test Assessment
Jayawant N. Mandrekar
JOURNAL OF THORACIC ONCOLOGY (2010)
Export of microRNAs and microRNA-protective protein by mammalian cells
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Hua Zhao et al.
PLOS ONE (2010)
Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves
Birgit Grund et al.
CURRENT OPINION IN HIV AND AIDS (2010)
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
Maria Angelica Cortez et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Olle Melander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Technical variables in high-throughput miRNA expression profiling: Much work remains to be done
Peter T. Nelson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
William Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
SMAD proteins control DROSHA-mediated microRNA maturation
Brandi N. Davis et al.
NATURE (2008)
Neoadjuvant chemotherapy for operable breast cancer
J. S. D. Mieog et al.
BRITISH JOURNAL OF SURGERY (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
Random-effects model for meta-analysis of clinical trials: An update
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
Origins of breast cancer subtypes and therapeutic implications
Andrew H. Sims et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Multiple biomarkers for the prediction of first major cardiovascular events and death
Thomas J. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
JB Reitsma et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
MicroRNA genes are transcribed by RNA polymerase II
Y Lee et al.
EMBO JOURNAL (2004)
Share Paper
